Evaluating Treatments for Amyotrophic Lateral Sclerosis
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Evaluating Treatments for Amyotrophic Lateral Sclerosis
-
Narrated by:
-
By:
About this listen
The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD.
Related Content:
- Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments
- Pridopidine in Amyotrophic Lateral Sclerosis
- Platform Trials in ALS
- Verdiperstat in Amyotrophic Lateral Sclerosis
- Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
- CNM-Au8 in Amyotrophic Lateral Sclerosis
activate_mytile_page_redirect_t1
What listeners say about Evaluating Treatments for Amyotrophic Lateral Sclerosis
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.